FamiCord Investor Relations Material
Latest events
Q1 2025
28 May, 2025
Q4 2024
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from FamiCord AG
Access all reports
FamiCord AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company also manufactures and sells reagents for bone marrow diagnostics. Its products include frozen cord blood units, partal bio-banking, culture and expansion f IMR90 K1, hematopoietic stem cells, adult progenitor cells, endothelial progenitor cells Mitomycin C; Vitapur; Vitafrost; Vitastem ampoules; sweet-hand sterilization bags for various applications; freezing bag for ten freezing bags; and pipette with tips. The company was founded in 1997 and is headquartered in Leipzig, Germany.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
V3V
Country
🇩🇪 Germany